Newell is Vice President, Health Economics and Outcomes Research at Boehringer Ingelheim Pharmaceuticals, Inc. He is a recognized leader in HEOR with 30 years experience in the pharmaceutical industry.  Prior to coming to Boehringer Ingelheim, Newell led outcomes research groups at Pfizer and Merck.  He has been actively engaged with a number of outcomes research related organizations, is a past ISPOR Board member and currently chairs the ISPOR Health Science Policy Council. 
Newell received his PharmD from Mercer University and his MSPH (epidemiology) from the University of Utah.  He completed a clinical pharmacy residency at Osteopathic Medical Center of Texas and a post-doctoral fellowship in clinical pharmacology and toxicology at the University of Utah Medical Center